Comparison of Mastoscopic and Conventional Axillary Lymph Node Dissection in Breast Cancer: Long-term Results from a Randomized, Multicenter Trial
Overview
Authors
Affiliations
Objective: To compare the long-term results of mastoscopic axillary lymph node dissection (MALND) and conventional axillary lymph node dissection (CALND).
Patients And Methods: From January 1, 2003, through December 31, 2005, a group of 1027 consecutive patients with operable breast cancer were randomly assigned to 1 of 2 study groups: MALND and CALND. The median follow-up was 63 months. The primary end points of the study were operative outcomes, complication reduction, function conservation, and cosmetics. The secondary end points were disease-free and overall survival.
Results: The mean operative blood loss in the MALND group was less than in the CALND group (P<.001). The patients who underwent MALND had less axillary pain, numbness or paresthesias, and arm swelling (P<.001). The aesthetic appearance of the axilla in the MALND group was much better than that in the CALND group (P=.001 at 6 months and P=.002 at 24 months). A significant difference was found between the 2 groups in distant metastasis (P=.04). The disease-free survival rate was 64.5% in the MALND group and 60.8% in the CALND group (P=.88). The overall survival rate was 81.7% in the MALND group and 78.6% in the CALND group (P=.95).
Conclusion: Compared with CALND, MALND has advantages in operative outcomes, complication reduction, function conservation, and cosmetics.
Ma Q, Shi T, Wang H, Xing J Open Med (Wars). 2025; 20(1):20241133.
PMID: 39844785 PMC: 11751671. DOI: 10.1515/med-2024-1133.
Ma T, Cui J, Wang Q, Liu C, Wang B, Wang H BMC Womens Health. 2025; 25(1):26.
PMID: 39825383 PMC: 11740456. DOI: 10.1186/s12905-025-03563-z.
Sae-Lim C, Lai H, Chennavasin P, Huang H, Lin S, Huang R Breast J. 2025; 2024:6319218.
PMID: 39742375 PMC: 11634405. DOI: 10.1155/tbj/6319218.
Li L, Liang Y, Li C, Huang M, Liang W, Qin T Front Oncol. 2024; 14:1419123.
PMID: 39165683 PMC: 11333215. DOI: 10.3389/fonc.2024.1419123.
Jiang Q, Liao J, Tan J, Hu H World J Surg Oncol. 2024; 22(1):183.
PMID: 39010087 PMC: 11251114. DOI: 10.1186/s12957-024-03447-w.